Back
Stoke Therapeutics Stock Price Chart
Sponsored
STOK
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
STOK
Stoke Therapeutics
Last Price:
11.57
Seasonality Move:
-1.15%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STOK is experiencing slight selling pressure.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.76 | Sell |
20-day SMA: | 12.75 | Sell |
50-day SMA: | 12.87 | Sell |
200-day SMA: | 12.28 | Sell |
8-day EMA: | 12.34 | Sell |
20-day EMA: | 12.67 | Sell |
50-day EMA: | 12.95 | Sell |
200-day EMA: | 12.11 | Sell |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 33.87 | Sell |
Chaikin Money Flow: | -45377 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.99 - 13.47) | Sell |
Bollinger Bands (100): | (12.44 - 14.7) | Sell |
Stoke Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 11.31 while STOK 8-day simple moving average is 12.76, which is a Sell signal.
- The stock price of STOK is 11.31 while Stoke Therapeutics 20-day SMA is 12.75, which makes it a Sell.
- Stoke Therapeutics 50-day simple moving average is 12.87 while STOK share price is 11.31, making it a Sell technically.
- STOK stock price is 11.31 and Stoke Therapeutics 200-day simple moving average is 12.28, creating a Sell signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
20
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a Sell
The current Stoke Therapeutics [STOK] share price is $11.31. The Score for STOK is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
599.06M
Price in USD:
11.31
Share Volume:
265.1K
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
3.77
Sell
20
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?
The Stoke Therapeutics stock price is 11.31 USD today. -
Will STOK stock go up or go down?
Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Stoke Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
- Stoke Therapeutics share price is 11.31 while STOK 8-day exponential moving average is 12.34, which is a Sell signal.
- The stock price of STOK is 11.31 while Stoke Therapeutics 20-day EMA is 12.67, which makes it a Sell.
- Stoke Therapeutics 50-day exponential moving average is 12.95 while STOK share price is 11.31, making it a Sell technically.
- STOK stock price is 11.31 and Stoke Therapeutics 200-day simple moving average is 12.11, creating a Sell signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.47 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
- STOK Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Stoke Therapeutics is a Sell
- Stoke Therapeutics Relative Strength Index (RSI) is 33.87, which suggest Stoke Therapeutics is oversold
- The Bollinger Bands (25) for Stoke Therapeutics is (11.99 - 13.47), which suggest Stoke Therapeutics is a Sell
- The Bollinger Bands (100) for Stoke Therapeutics is (12.44 - 14.7), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.